ArticleAmerican journal of translational research2026
Overweight and obesity are associated with poorer treatment response and impaired pulmonary function in children with bronchial asthma: a retrospective study.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the effect of body mass index (BMI) on standardized treatment efficacy and pulmonary function in children with bronchial asthma.
methodsClinical data of 120 children with acute asthma attacks (January 2020-December 2023) were retrospectively analyzed. Children were divided into a normal-weight group (16th- < 85th percentile, n=62) and an overweight/obese group (≥ 85th percentile, n=58). Both received standardized treatment. Clinical efficacy, CACT scores, annual attack frequency, emergency visits, inflammatory markers, and pulmonary function were compared.
resultsThe normal weight group showed significantly higher total effective rate (93.5% vs. 79.3%, P=0.022), better CACT scores post-treatment (23.5 ± 2.8 vs. 19.8 ± 3.2, P < 0.001), and fewer annual attacks (3.2 ± 1.5 vs. 5.6 ± 1.8, P < 0.001) and emergency visits (1.8 ± 1.0 vs. 3.4 ± 1.3, P < 0.001). Both groups improved in pulmonary function and inflammatory factors (all P < 0.05), but the improvement rates in FEV
conclusionOverweight and obesity are associated with poorer treatment response, less pulmonary function improvement, and worse disease control in asthmatic children. Weight management should be emphasized in this population to optimize therapeutic outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.